Identification of dengue-specific B-cell epitopes by phage-display random peptide library

Malaysian Journal of Medical Sciences

Volumn 16, Issue 4, 2009, Pages 4-14

  Amin, Nevis ^a   Aguilar, Alicia ^a   Chamacho, Frank ^a   Vázquez, Yaime ^b   Pupo, Maritza ^b   Ramirez, Juan Carlos ^a   Izquierdo, Luis ^a   Dafhnis, Felix ^a   Stott, David Ian ^c   Perez, Ela Maria ^a   Acosta, Armando ^a  

^a FINLAY INSTITUTE   (Cuba)

^b INSTITUTO DE MEDICINA TROPICAL PEDRO KOURÍ   (Cuba)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Dengue; Epitopes; Medical sciences; Virology

Indexed keywords

EPITOPE; NONSTRUCTURAL PROTEIN 3; NONSTRUCTURAL PROTEIN 4B; PEPTIDE LIBRARY; POLYCLONAL ANTIBODY; VIRUS ANTIBODY;

AMINO ACID SEQUENCE; ANTIGEN BINDING; ARTICLE; ASCITES FLUID; B LYMPHOCYTE; BINDING AFFINITY; CLONE; CONTROLLED STUDY; DENGUE VIRUS; DNA SEQUENCE; EASTERN EQUINE ENCEPHALOMYELITIS VIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; HYPERIMMUNE ASCITIC FLUID; NONHUMAN; PHAGE DISPLAY; PROTEIN ANALYSIS; PROTEIN ISOLATION; PROTEIN STRUCTURE; SEROTYPE; SERUM; WEST NILE FLAVIVIRUS;

EID: 75149118279     PISSN: 1394195X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Gubler DJ. Dengue and dengue hemorrhagic fever. Clin Microbiol Rev. 1998;11:480-496.
2. Lidenbach BD, Rice CM. Flaviviruses. In: Knipe DM, Howley PM editors. Fields Virology. Philadelphia: Lippincott Williams and Wilkins. 2001;p.991-1041.
3. Roehrig JT. Antigenic structure of flavivirus proteins. Adv Virus Res. 2003;59: 141-175.
4. Se-Thoe SY, Ng MM, Ling AE. Retrospective study of Western Blott profiles in immune sera of natural dengue virus infections. J Med Virol. 1999;57:322-330.
5. Churdboonchart V, Bhamarapravati N, Peampramprecha S, Sirinavin S. Antibodies against dengue viral proteins in primary and secondary dengue hemorrhagic fever. Am J Trop Med Hyg. 1991;44:481-493.
6. Valdés K, Alvarez M, Pupo M, Vázquez S, Rodríguez R, Guzmán MG. Human dengue antibodies against structural and nonstructral proteins. Clin Diagn Lab Immunol. 2000;7:856-857.
7. Cortés LM, Barth OM, Pantoja JR, Alves CR. Comparative immunological recognition of proteins from new Guinea "C" dengue virus type 2 prototype and from a dengue virus type 2 strain isolated in the State of Rio de Janeiro, Brazil. Mem Inst Oswaldo Cruz. 2003;98:331-334.
8. dos Santos FB, Miagostovich MP, Nogueira RM, Schatzmayr HG, Riley LW, Harris E. Analysis of recombinant dengue virus polypeptides for dengue diagnosis and evaluation of the humoral immune response. Am J Trop Med Hyg. 2004;71:144-152.
9. Lázaro L, Mellado G, García J, Escobar A, Santos L, Gutiérrez B, et al. Analysis of antibody responses in human dengue patients from the Mexican coast using recombinant antigens. Vector Borne Zoonotic Dis. 2008;8:69-79.
10. Gubler DJ. Dengue hemorrhagic fever: its history and resurgence as a global public health problem. In: Gubler DJ, Kuno G editors. Dengue and dengue hemorrhagic fever.. London, UK: CAB International. 1997;p.1-22.
11. Gubler DJ, Casta-Velez A. A program for prevention and control of epidemic dengue and dengue hemorrhagic fever in Puerto Rico and the U.S. Virgin Islands. Bull Pan Am Health Organ. 1991;25:237-247.
12. AnandaRao R, Swaminathan S, Fernando S, Jana AM, Khanna N. Recombinant multiepitope protein for early detection of dengue infections. Clin Vaccine Immunol. 2006;13:59-67.
13. Guzmán MG, Kourí G. Dengue: an update. Lancet Infect Dis. 2001;2:33-42.
14. Rothman AL. Dengue: defining protective versus pathologic immunity. J Clin Invest. 2004;113:946-951.
15. Folgori AT, Felici R, Galfre F, Cortese G, Monaci R, Nicosi A. A general strategy to identify mimotopes of pathological antigens using only random peptides libraries and human sera. EMBO J. 1994;13:2236-2243.
16. Yao ZJ, Kao M, Loh KC, Chung M. A serotype-specific epitope of dengue virus 1 identified by phage displayed random peptide library. FEMS Microbiol Lett. 1995;127:93-98.
17. Wu HC, Huang Yl, Chao TT, Jan JT, Huang JL, Chiang HY et al. Identification of B-cell epitopes of dengue virus type 1 and its application in diagnosis of patients. J Clin Microbiol. 2001;39:977-982.
18. Wu HC, Jung MY, Chiu CY, Chao TT, Lai SC, Jan JT et al. Identification of a dengue virus type (DEN-2) serotype specific B cell epitope and detection of dengue 2 immunized animal serum samples using an epitopes based peptide antigen. J Gen Virol. 2003;84:2771-2779.
19. Chen YC, Huang HN, Lin CT, Chen YF, King CC, Wu HC. Generation and characterization of monoclonal antibodies against dengue virus Type 1 for epitope mapping and serological detection by epitope-based peptide antigens. Clin Vaccine Immunol. 2007;14:404-411.
20. Vazquez S, Bravo JR, Perez AB, Guzman MG. Inhibition ELISA. Its utility for classifying a case of dengue. Rev Cubana Med Trop. 1997;49:108-112.
21. Russell PK, Nisalak A, Sukhavachana, Vivona S. A plaque reduction test for dengue virus neutralizing antibodies. J Immunol. 1967;99:285- 290.
22. Larralde O, Stott D, Martinez R, Camacho F, Amin N, Aguilar A et al. Identification of hepatitis A virus mimotopes by phage display, antigenicity and immunogenicity. J Virol Meth. 2007;140:49-58.
23. Burritt JB, Bond CW, Doss KW, Jesaitis AJ. Filamentous phage display of oligopeptide libraries. Anal Bioche. 1996;238:1-13.
24. Sambrook J, Russell DW. Molecular Cloning. A Laboratory Manual, 3rd ed. New York: Cold Spring Harbor Laboratory Press. 2001.
25. Hermida C, Pupo M, Guzmán MG, González MC, Marcet R. Use of a dengue anti-complex monoclonal antibody in viral purification. Rev Cubana Med Trop. 1992;44:376-396.
26. Burritt JB, Quinn MT, Jutila MA, Bond C, Jesaitis AJ. Topological mapping of neutrophil cytochrome b epitopes with phage-display libraries. J Biol Chem. 1995;270:16974-16980.
27. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol. 1990;215:403-410.
28. Delmastro P, Meola A, Monaci P, Cortese R, Galfre G. Immunogenicity of filamentous phage displaying peptide mimotopes after oral administration. Vaccine. 1997;15:1276-12785.
29. Menendez A, Scott JK. The nature of target-unrelated peptides recovered in the screening of phage-displayed random peptide libraries with antibodies. Anal. Biochem. 2005;336:145-157.
30. Wang LF, Yo M. Epitope identification and discovery using phage display libraries: applications in vaccine development and diagnostics. Curr Drug Targets. 2004;5:1-15.
31. Yang WJ, JF Lai, Peng KC, Chinag HJ, Weng CN, Shivan D. Epitope mapping of mycoplasms hyopneumniaue using phage displayed peptide libraries and the immune responses of the selected phagotopes. J Immunol Methods. 2005;304:15-29.
32. Lanzillotti R, Coetzer TL. Phage display: a useful tool for malaria research? Trends Parasitol. 2008;24:18-23.
33. Yu H, Jiang LF, Fang DY, Zheu JJ, Zhou JM, Liang Y, et al. Selection of SARS-coronavirus specific B cell epitopes by phage peptide library screening and evaluation of the immunological effect of epitope based peptides on mice. Virology. 2007; 359: 264-274.
34. Yang G, Gao Y, Dong Y, Xue Y, Fang M, Shen B et al. A novel peptide isolated from phage library to substitute a complex system for a vaccine agaisnt staphylococci infection. Vaccine. 2006;24:1117-1123.
35. Irving MB, Pan O, Scott JK. Random-peptide libraries and antigen-fragment libraries for epitope mapping and the development of vaccines and diagnostics. Curr Opin Chem Biol. 2001;5:314-324.
36. Zhang WY, Wan Y, Li DG, Tang Y, Zhou W. A mimotope of pre-S2 region of surface antigen of viral hepatitis B screened by phage display. Cell Res. 2001;11:203-208.
37. Beckmann C, Brittnacher M, Ernst R, Mayer-Hamblett N, Miller SI, Burns JL. Use of phage display to identify potential Pseudomonas aeruginosa gene products relevant to early cystic fibrosis airway infections. Infect Immun. 2005;73:444-452.
38. Henchal EA, Putnak JR. The dengue viruses. Clin Microbiol Rev. 1990;3:376-396.
39. Khan AM, Miotto O, Nascimento E, Srinivasan KN, Heiny AT, Zhang GL et al. Conservation and variability of dengue virus proteins: Implications for vaccine design. PLoS Negl Trop Dis 2008;2:e272.1
40. Appanna R, Huat TL, Chai See LL, Tan PL, Vadivelu J, Devi S. Cross reactive T cell responses to the nonstructual regions of dengue viruses among dengue fever an dengue hemorrhagic fever patients in Malaysia. Clin Vaccine Immunol. 2007;14:969-977.
41. Lobigs M, Arthur CE, Mullbacher A, Blanden RV. The flavivirus nonstructural protein NS3 is a dominant source of cytotoxic T cell peptide determinants. Virology. 1994;240:169-174.